Showing results (111-120 of 312) with videos related to

Sort By:
Pageof 32
Oncology|January 14, 1999
Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experienceC Kollmannsberger, K Mross, A Jakob, et al.
Current Opinion in Urology|September 27, 2000
Sexual function and fertility after treatment of testicular cancerM Kuczyk, S Machtens, C Bokemeyer, et al.
British Journal of Cancer|May 1, 1996
Endocrinological late effects after chemotherapy for testicular cancerC C Berger, C Bokemeyer, F Schuppert, et al.
Hamostaseologie|September 11, 2012
Successful eradication of a FVIII inhibitor in a 60-year-old patient with mild haemophilia A using single-agent prednisoloneK Holstein, G Marx, B Lentz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2016
Expression and release of platelet protein disulphide isomerase in patients with haemophilia AM Voigtlaender, K Holstein, B Spath, et al.
British Journal of Cancer|December 4, 2003
Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitroS Koch, F Mayer, F Honecker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustineU Reichmann, C Bokemeyer, D Wallwiener, et al.
Annals of Hematology|May 10, 2000
Thyroid toxicity of treatment for Hodgkin's diseaseW Bethge, D Guggenberger, M Bamberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumorsF Mayer, F Honecker, L H J Looijenga, et al.
World Journal of Urology|May 26, 2001
Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapyC Kollmannsberger, F Mayer, M Kuczyk, et al.
Pageof 32